We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Chemours
CC
$2.59B
| $1.56M | 0.01% |
97,462
-2,158
| -2% | -$24.6K |
|
|
EEP
602
DELISTED
Enbridge Energy Partners
EEP
| $1.55M | 0.01% |
61,173
+34,740
| +131% | +$835K |
|
603
W.P. Carey
WPC
$17.1B
| $1.55M | 0.01% |
24,489
-483
| -2% | -$32.2K |
|
604
Crane NXT
CXT
$3.04B
| $1.54M | 0.01% |
70,461
+66,142
| +1,531% | +$1.42M |
|
605
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.53M | 0.01% |
16,562
-77
| -0.5% | -$7.25K |
|
|
TGP
606
DELISTED
Teekay LNG Partners L.P.
TGP
| $1.53M | 0.01% |
101,081
-1,975
| -2% | -$24.8K |
|
607
Federal Signal
FSS
$7.25B
| $1.52M | 0.01% |
115,060
-25,840
| -18% | -$340K |
|
608
Eastman Chemical
EMN
$7.8B
| $1.52M | 0.01% |
22,462
-4,901
| -18% | -$329K |
|
|
ACOR
609
DELISTED
Acorda Therapeutics
ACOR
| $1.52M | 0.01% |
606
-80
| -12% | -$239K |
|
610
Universal Health Services
UHS
$9.43B
| $1.51M | 0.01% |
12,289
+215
| +2% | +$27.2K |
|
|
SPR
611
DELISTED
Spirit AeroSystems
SPR
| $1.51M | 0.01% |
33,908
-273,204
| -89% | -$12.1M |
|
|
DCP
612
DELISTED
DCP Midstream, LP
DCP
| $1.49M | 0.01% |
42,325
+41,625
| +5,946% | +$1.42M |
|
613
Vanguard Value ETF
VTV
$189B
| $1.49M | 0.01% |
17,157
+6,603
| +63% | +$575K |
|
614
Middleby
MIDD
$6.05B
| $1.49M | 0.01% |
12,061
-71
| -0.6% | -$8.72K |
|
615
EOG Resources
EOG
$78B
| $1.48M | 0.01% |
15,292
+69
| +0.5% | +$6.06K |
|
616
Reinsurance Group of America
RGA
$15.7B
| $1.47M | 0.01% |
13,597
-325
| -2% | -$33.2K |
|
|
ENH
617
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $1.45M | 0.01% |
22,235
-153
| -0.7% | -$10.1K |
|
618
Philips
PHG
$25.4B
| $1.45M | 0.01% |
66,323
+12
| +0% | +$246 |
|
|
OKS
619
DELISTED
Oneok Partners LP
OKS
| $1.43M | 0.01% |
35,800
-435
| -1% | -$17.4K |
|
620
Commercial Metals
CMC
$7.63B
| $1.4M | 0.01% |
86,720
| – | – |
|
621
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
| $1.38M | 0.01% |
57,648
| – | – |
|
622
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
| $1.37M | 0.01% |
25,420
-400
| -2% | -$21.3K |
|
623
Quanta Services
PWR
$93.9B
| $1.37M | 0.01% |
48,928
| – | – |
|
|
SNCR
624
DELISTED
Synchronoss Technologies
SNCR
| $1.37M | 0.01% |
4,898
+3,757
| +329% | +$1.33M |
|
|
SYKE
625
DELISTED
SYKES Enterprises Inc
SYKE
| $1.36M | 0.01% |
48,432
-36,100
| -43% | -$1.07M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.